| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,614 |
8,836 |
$876K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,124 |
6,144 |
$839K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,329 |
3,443 |
$788K |
| G0378 |
Hospital observation service, per hour |
769 |
520 |
$185K |
| 71046 |
Radiologic examination, chest; 2 views |
2,284 |
1,933 |
$114K |
| 80050 |
General health panel |
2,621 |
2,455 |
$109K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,077 |
945 |
$80K |
| 80053 |
Comprehensive metabolic panel |
11,212 |
7,899 |
$75K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,933 |
8,636 |
$62K |
| 71045 |
Radiologic examination, chest; single view |
1,647 |
1,342 |
$59K |
| 70450 |
Computed tomography, head or brain; without contrast material |
188 |
167 |
$57K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,874 |
1,506 |
$56K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,884 |
2,314 |
$52K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,090 |
1,902 |
$51K |
| 70220 |
|
604 |
531 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
20,897 |
15,512 |
$45K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
8,960 |
6,893 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,127 |
2,310 |
$38K |
| 80061 |
Lipid panel |
2,893 |
2,648 |
$33K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
642 |
501 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,666 |
1,219 |
$32K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
214 |
197 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,397 |
1,073 |
$26K |
| 82607 |
|
1,961 |
1,820 |
$25K |
| 74022 |
|
308 |
291 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
61 |
59 |
$22K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
472 |
361 |
$21K |
| 81001 |
|
8,839 |
7,444 |
$21K |
| 83880 |
|
729 |
649 |
$19K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
14 |
13 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,167 |
1,029 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,763 |
1,606 |
$14K |
| 83735 |
|
2,530 |
2,302 |
$14K |
| 87428 |
|
678 |
628 |
$13K |
| 87088 |
|
1,697 |
1,466 |
$12K |
| 83525 |
|
1,122 |
1,018 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
928 |
790 |
$10K |
| 84484 |
|
1,219 |
866 |
$10K |
| 84481 |
|
685 |
628 |
$8K |
| 83690 |
|
1,424 |
1,196 |
$7K |
| 0002A |
|
236 |
165 |
$7K |
| 84439 |
|
819 |
742 |
$6K |
| 0001A |
|
176 |
146 |
$5K |
| 99220 |
|
87 |
78 |
$5K |
| 86376 |
|
379 |
347 |
$5K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
17 |
14 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
14 |
13 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
150 |
130 |
$4K |
| 72100 |
|
70 |
67 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
28 |
26 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
299 |
276 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
12 |
$3K |
| 93041 |
|
1,171 |
507 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
42 |
37 |
$3K |
| 86308 |
|
539 |
475 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
113 |
107 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
538 |
463 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
43 |
37 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
70 |
31 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
27 |
12 |
$2K |
| 82746 |
|
179 |
166 |
$2K |
| 82150 |
|
396 |
362 |
$2K |
| 74019 |
|
33 |
24 |
$2K |
| 81025 |
|
280 |
254 |
$2K |
| 96376 |
|
59 |
29 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$2K |
| 87807 |
|
112 |
100 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
44 |
32 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
91 |
53 |
$1K |
| 99218 |
|
48 |
42 |
$1K |
| 93017 |
|
15 |
14 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
59 |
44 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
26 |
25 |
$916.65 |
| 83605 |
|
112 |
100 |
$833.04 |
| 89220 |
|
63 |
59 |
$737.77 |
| 86140 |
|
214 |
179 |
$701.95 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
312 |
271 |
$667.84 |
| 0003A |
|
13 |
13 |
$654.64 |
| 82670 |
|
27 |
24 |
$642.62 |
| 87186 |
|
75 |
63 |
$582.93 |
| 87077 |
|
75 |
63 |
$544.65 |
| 82043 |
|
103 |
92 |
$508.64 |
| 81000 |
|
158 |
132 |
$406.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
77 |
71 |
$405.84 |
| 84100 |
|
103 |
100 |
$388.68 |
| 81003 |
|
184 |
159 |
$351.60 |
| G0238 |
Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) |
33 |
30 |
$325.04 |
| 86665 |
|
16 |
15 |
$271.79 |
| 94760 |
|
540 |
464 |
$267.32 |
| 85651 |
|
69 |
67 |
$230.58 |
| 86664 |
|
16 |
15 |
$229.09 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
14 |
14 |
$226.94 |
| 83615 |
|
44 |
44 |
$223.48 |
| 86663 |
|
16 |
15 |
$196.58 |
| 85027 |
|
30 |
26 |
$172.32 |
| 86337 |
|
15 |
14 |
$170.76 |
| C9113 |
Injection, pantoprazole sodium, per vial |
13 |
13 |
$168.33 |
| 86677 |
|
14 |
12 |
$158.20 |
| 85610 |
|
47 |
44 |
$129.81 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
15 |
14 |
$85.30 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
17 |
16 |
$76.15 |
| 84550 |
|
16 |
16 |
$63.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$61.38 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
13 |
12 |
$47.02 |
| J7050 |
Infusion, normal saline solution, 250 cc |
15 |
12 |
$24.25 |
| 94761 |
|
16 |
12 |
$14.35 |
| 91300 |
|
489 |
360 |
$1.47 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
551 |
450 |
$0.00 |
| 82948 |
|
31 |
26 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
12 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
14 |
13 |
$0.00 |
| 00000 |
|
26 |
25 |
$0.00 |